Medley Capital Corporation (NYSE: MCC) (TASE: MCC) (the “Company”)
today announced financial results for its second fiscal quarter
ended March 31, 2019.
Second Quarter Highlights
- Net investment loss of $(0.19) per share
- Adjusted net investment income of $0.01 per share excluding
expenses associated with pending merger
- Net asset value (“NAV”) of $5.11 per share, which includes
$0.21 per share impact of merger related expenses
- The board of directors did not declare a dividend this
quarter
Merger Update1
- On April 18, 2019, the shareholder vote was postponed
- The Company is pursuing amendments to the previously announced
merger agreement
Portfolio Investments
The total value of our investments was $612.5
million at March 31, 2019. During the quarter ended March 31, 2019,
the Company originated $13.3 million of investments and had $31.0
million of repayments, resulting in net repayments of $17.7
million. As of March 31, 2019, the Company had investments in
securities of 60 portfolio companies with approximately 60.7%
consisting of senior secured first lien investments, 5.9%
consisting of senior secured second lien investments, 0.4%
consisting of unsecured debt, 12.3% in MCC Senior Loan Strategy JV
and 20.7% in equities / warrants. As of March 31, 2019, the
weighted average yield based upon the cost basis of our income
bearing portfolio investments, excluding cash and cash equivalents,
was 9.5%.
Results of Operations
For the three months ended March 31, 2019, the
Company reported net investment loss per share and net loss per
share of $(0.19) and $(0.45), respectively, calculated based upon
the weighted average shares outstanding. Adjusted net investment
income was $0.01 per share, which excludes $11.2 million of
expenses associated with the pending merger. As of March 31, 2019,
the Company’s NAV was $5.11 per share, which included a reduction
of $0.21 per share from litigation and merger related
expenses. Excluding these litigation and merger related
expenses NAV would have been $5.32 per share. The Company is
seeking reimbursement under its insurance coverage for the
litigation related expenses and any reimbursements received will
result in an increase in NAV.
Investment Income
For the three months ended March 31, 2019, total
investment income was $12.6 million and consisted of $10.3 million
of portfolio interest income, $2.0 million of dividend income, and
$0.3 million of fee income.
For the six months ended March 31, 2019, total
investment income was $26.8 million and consisted of $21.9 million
of portfolio interest income, $4.1 million of dividend income, and
$0.8 million of fee income.
Expenses
For the three months ended March 31, 2019, total
expenses were $23.2 million and consisted of the following: base
management fees of $3.1 million, interest and financing expenses of
$5.9 million, professional fees of $10.2 million, administrator
expenses of $0.7 million, directors’ fees of $0.4 million, and
other general and administrative related expenses of $2.9
million.
For the six months ended March 31, 2019, total
expenses were $35.6 million and consisted of the following: base
management fees of $6.3 million, interest and financing expenses of
$11.9 million, professional fees of $11.4 million, administrator
expenses of $1.7 million, directors’ fees of $0.7 million, and
other general and administrative related expenses of $3.6
million.
Net Investment Income
For the three months ended March 31, 2019, the
Company reported net investment loss of $(10.6) million, or
$(0.19), on a weighted average per share basis.
For the six months ended March 31, 2019, the
Company reported net investment loss of $(8.8) million, or $(0.16),
on a weighted average per share basis.
Net Realized and Unrealized Gains/Losses
For the three and six months ended March 31,
2019, the Company reported net realized losses of $(10.6) million
and $(67.3) million, respectively.
For the three months ended March 31, 2019, the
Company did not have a loss on extinguishment of debt. For the six
months ended March 31, 2019, the Company reported a loss on
extinguishment of debt of $(0.1) million.
For the three and six months ended March 31,
2019, the Company reported net unrealized depreciation on
investments of $(3.4) million, and net unrealized appreciation on
investments of $41.6 million, respectively.
Liquidity and Capital
Resources
As of March 31, 2019, the Company had a cash
balance of $73.4 million, of which $53.3 million was held by Medley
SBIC, LP.
As of March 31, 2019, the Company had $135.0
million outstanding in SBA-guaranteed Debentures (the “SBA
Debentures”), $74.0 million outstanding in aggregate principal
amount of 6.5% unsecured notes due 2021, $77.8 million outstanding
in aggregate principal amount of 6.125% unsecured notes due 2023,
and $120.2 million outstanding in aggregate principal amount of
5.55% unsecured notes due 2024. As of May 10, 2019, the Company has
fully repaid its SBA Debentures.
Dividend Declaration
The board of directors did not declare a
dividend this quarter.
2019 Annual Meeting of
Stockholders
The 2019 Annual Meeting of Stockholders is to be
held at the offices of Eversheds Sutherland (US) LLP, located at
1114 Avenue of the Americas, 40th Floor, New York, New York 10036,
on June 4, 2019 at 12:00 p.m., Eastern Time. Our Proxy Statement
and Annual Report on Form 10-k for the fiscal year ended September
30, 2018, are available on the Internet through our website at
http://www.medleycapitalcorp.com.
Webcast/Conference Call
The Company will host an earnings conference
call and audio webcast at 10:00 a.m. (Eastern Time) on Monday, May
13, 2019. The Company plans to place additional materials related
to the earnings announcement, including a slide presentation, on
its website prior to the conference call.
All interested parties may participate in the
conference call by dialing (888) 637-5728 approximately 5-10
minutes prior to the call, international callers should dial (484)
747-6636. Participants should reference Medley Capital Corporation
and the Conference ID: 4494743. Following the call you may access a
replay of the event via audio webcast. This conference call will be
broadcast live over the Internet and can be accessed by all
interested parties through the Company's website,
http://www.medleycapitalcorp.com. To listen to the live call,
please go to the Company's website at least 15 minutes prior to the
start of the call to register and download any necessary audio
software. For those who are not able to listen to the live
broadcast, a replay will be available shortly after the call on the
Company's website.
Financial Statements
Medley Capital
CorporationConsolidated Statements of Assets and
Liabilities(in thousands, except share and per
share data)
|
March 31, 2019 |
|
September 30, 2018 |
|
(unaudited) |
|
|
ASSETS |
|
|
|
Investments at fair value |
|
|
|
Non-controlled/non-affiliated investments (amortized cost of
$366,735 and $428,718, respectively) |
$ |
351,330 |
|
|
$ |
393,149 |
|
Affiliated investments (amortized cost of $125,596 and $428,718,
respectively) |
118,216 |
|
|
100,641 |
|
Controlled investments (amortized cost of $187,816 and $428,718,
respectively) |
142,954 |
|
|
161,640 |
|
Total investments at fair
value |
612,500 |
|
|
655,430 |
|
Cash and cash equivalents |
73,407 |
|
|
75,666 |
|
Interest receivable |
5,779 |
|
|
6,377 |
|
Other assets |
3,135 |
|
|
3,421 |
|
Receivable for dispositions
and investments sold |
512 |
|
|
160 |
|
Fees receivable |
200 |
|
|
187 |
|
Deferred offering costs |
— |
|
|
355 |
|
Total assets |
$ |
695,533 |
|
|
$ |
741,596 |
|
|
|
|
|
LIABILITIES |
|
|
|
Notes payable (net of debt
issuance costs of $6,870 and $8,238, respectively) |
$ |
265,156 |
|
|
$ |
276,909 |
|
SBA debentures payable (net of
debt issuance costs of $1,881 and $2,095, respectively) |
133,119 |
|
|
132,905 |
|
Accounts payable and accrued
expenses |
11,788 |
|
|
2,936 |
|
Management and incentive fees
payable |
3,084 |
|
|
3,348 |
|
Interest and fees payable |
3,008 |
|
|
3,280 |
|
Administrator expenses
payable |
668 |
|
|
808 |
|
Due to affiliate |
276 |
|
|
39 |
|
Deferred revenue |
113 |
|
|
192 |
|
Total liabilities |
$ |
417,212 |
|
|
$ |
420,417 |
|
|
|
|
|
NET ASSETS |
|
|
|
Common stock, par value $0.001
per share, 100,000,000 common shares authorized, 54,474,211 and
54,474,211 common shares issued and outstanding, respectively |
$ |
54 |
|
|
$ |
54 |
|
Capital in excess of par
value |
698,587 |
|
|
698,587 |
|
Total distributable
earnings/(loss) |
(420,320 |
) |
|
(377,462 |
) |
Total net assets |
278,321 |
|
|
321,179 |
|
Total liabilities and net
assets |
$ |
695,533 |
|
|
$ |
741,596 |
|
|
|
|
|
NET ASSET VALUE PER SHARE |
$ |
5.11 |
|
|
$ |
5.90 |
|
|
|
|
|
|
|
|
|
Medley Capital
CorporationConsolidated Statements of
Operations(in thousands, except share and per
share data)
|
For the three months ended March
31 |
|
For the six months ended March
31 |
|
2019 |
|
2018 |
|
2019 |
|
2018 |
|
(unaudited) |
|
(unaudited) |
|
(unaudited) |
|
(unaudited) |
INVESTMENT INCOME |
|
|
|
|
|
|
|
Interest from investments |
|
|
|
|
|
|
|
Non-controlled/non-affiliated investments: |
|
|
|
|
|
|
|
Cash |
$ |
7,510 |
|
|
$ |
10,967 |
|
|
$ |
15,587 |
|
|
$ |
24,057 |
|
Payment-in-kind |
606 |
|
|
872 |
|
|
1,178 |
|
|
2,514 |
|
Affiliated investments: |
|
|
|
|
|
|
|
Cash |
460 |
|
|
491 |
|
|
1,212 |
|
|
1,068 |
|
Payment-in-kind |
644 |
|
|
770 |
|
|
1,616 |
|
|
1,619 |
|
Controlled investments: |
|
|
|
|
|
|
|
Cash |
86 |
|
|
426 |
|
|
164 |
|
|
856 |
|
Payment-in-kind |
760 |
|
|
815 |
|
|
1,789 |
|
|
1,534 |
|
Total interest income |
10,066 |
|
|
14,341 |
|
|
21,546 |
|
|
31,648 |
|
Dividend income |
1,992 |
|
|
2,173 |
|
|
4,091 |
|
|
3,616 |
|
Interest from cash and cash
equivalents |
211 |
|
|
26 |
|
|
373 |
|
|
58 |
|
Fee income |
318 |
|
|
495 |
|
|
779 |
|
|
2,344 |
|
Total investment income |
12,587 |
|
|
17,035 |
|
|
26,789 |
|
|
37,666 |
|
|
|
|
|
|
|
|
|
EXPENSES |
|
|
|
|
|
|
|
Base management fees |
3,084 |
|
|
3,776 |
|
|
6,270 |
|
|
7,844 |
|
Incentive fees |
— |
|
|
— |
|
|
— |
|
|
— |
|
Interest and financing
expenses |
5,899 |
|
|
7,470 |
|
|
11,908 |
|
|
14,229 |
|
Professional fees |
10,157 |
|
|
556 |
|
|
11,357 |
|
|
1,142 |
|
General and
administrative |
2,881 |
|
|
672 |
|
|
3,485 |
|
|
1,429 |
|
Administrator expenses |
668 |
|
|
956 |
|
|
1,700 |
|
|
1,824 |
|
Directors fees |
376 |
|
|
251 |
|
|
669 |
|
|
398 |
|
Insurance |
117 |
|
|
130 |
|
|
236 |
|
|
263 |
|
Expenses before management and incentive fee waivers |
23,182 |
|
|
13,811 |
|
|
35,625 |
|
|
27,129 |
|
Management fee waiver |
— |
|
|
(380 |
) |
|
— |
|
|
(380 |
) |
Incentive fee waiver |
— |
|
|
— |
|
|
— |
|
|
— |
|
Total expenses net of
management and incentive fee waivers |
23,182 |
|
|
13,431 |
|
|
35,625 |
|
|
26,749 |
|
Net investment income before excise taxes |
(10,595 |
) |
|
3,604 |
|
|
(8,836 |
) |
|
10,917 |
|
Excise tax expense |
— |
|
|
(24 |
) |
|
— |
|
|
(158 |
) |
NET INVESTMENT INCOME |
(10,595 |
) |
|
3,580 |
|
|
(8,836 |
) |
|
10,759 |
|
|
|
|
|
|
|
|
|
REALIZED AND UNREALIZED
GAIN/(LOSS) ON INVESTMENTS |
|
|
|
|
|
|
|
Net realized gain/(loss) from
investments |
|
|
|
|
|
|
|
Non-controlled/non-affiliated investments |
(10,615 |
) |
|
(23,331 |
) |
|
(15,799 |
) |
|
(23,352 |
) |
Affiliated investments |
— |
|
|
— |
|
|
— |
|
|
— |
|
Controlled investments |
— |
|
|
— |
|
|
(51,539 |
) |
|
— |
|
Net realized gain/(loss) from investments |
(10,615 |
) |
|
(23,331 |
) |
|
(67,338 |
) |
|
(23,352 |
) |
Net unrealized
appreciation/(depreciation) on investments |
|
|
|
|
|
|
|
Non-controlled/non-affiliated investments |
19,352 |
|
|
6,323 |
|
|
20,164 |
|
|
(28,147 |
) |
Affiliated investments |
(3,079 |
) |
|
(4,929 |
) |
|
(5,474 |
) |
|
(646 |
) |
Controlled investments |
(19,672 |
) |
|
(9,454 |
) |
|
26,920 |
|
|
(18,459 |
) |
Net unrealized appreciation/(depreciation) on investments |
(3,399 |
) |
|
(8,060 |
) |
|
41,610 |
|
|
(47,252 |
) |
Change in provision for
deferred taxes on unrealized (appreciation)/depreciation on
investments |
— |
|
|
190 |
|
|
— |
|
|
280 |
|
Net loss on extinguishment of
debt |
— |
|
|
(1,158 |
) |
|
(123 |
) |
|
(1,158 |
) |
Net realized and unrealized gain/(loss) on investments |
(14,014 |
) |
|
(32,359 |
) |
|
(25,851 |
) |
|
(71,482 |
) |
NET INCREASE/(DECREASE) IN NET
ASSETS RESULTING FROM OPERATIONS |
$ |
(24,609 |
) |
|
$ |
(28,779 |
) |
|
$ |
(34,687 |
) |
|
$ |
(60,723 |
) |
|
|
|
|
|
|
|
|
WEIGHTED AVERAGE - BASIC AND
DILUTED EARNINGS PER COMMON SHARE |
$ |
(0.45 |
) |
|
$ |
(0.53 |
) |
|
$ |
(0.64 |
) |
|
$ |
(1.11 |
) |
WEIGHTED AVERAGE - BASIC AND
DILUTED NET INVESTMENT INCOME PER COMMON SHARE |
$ |
(0.19 |
) |
|
$ |
0.07 |
|
|
$ |
(0.16 |
) |
|
$ |
0.20 |
|
WEIGHTED AVERAGE COMMON STOCK
OUTSTANDING - BASIC AND DILUTED |
54,474,211 |
|
|
54,474,211 |
|
|
54,474,211 |
|
|
54,474,211 |
|
DIVIDENDS DECLARED PER COMMON
SHARE |
$ |
0.05 |
|
|
$ |
0.16 |
|
|
$ |
0.15 |
|
|
$ |
0.32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial Measures
We make reference to certain non-GAAP financial
measures in this press release. The following table presents a
reconciliation of net investment income to adjusted net investment
income:
|
For the three months ended March 31, 2019 |
|
Total |
|
Per Share |
|
|
|
|
Net investment income/(loss) |
$ |
(10,594,688 |
) |
|
$ |
(0.19 |
) |
Add back Merger related
expenses |
11,238,385 |
|
|
0.21 |
|
Adjusted net investment
income |
$ |
643,697 |
|
|
$ |
0.01 |
|
|
|
|
|
|
|
|
|
Note: May not foot due to rounding.
The following table presents a reconciliation of
net asset value to adjusted net asset value:
|
As of March 31, 2019 |
|
Total |
|
Per Share |
|
|
|
|
Total net assets |
$ |
278,320,976 |
|
|
$ |
5.11 |
|
Add back Merger related
expenses |
11,238,385 |
|
|
0.21 |
|
Adjusted total net assets |
$ |
289,559,361 |
|
|
$ |
5.32 |
|
|
|
|
|
|
|
|
|
Merger related expenses primarily consist of
professional fees and proxy solicitation expenses.Per share amounts
are based on 54,474,211 weighted average shares outstanding for the
period.
ABOUT MEDLEY CAPITAL
CORPORATION
Medley Capital Corporation is a closed-end,
externally managed business development company ("BDC") that trades
on the New York Stock Exchange (NYSE: MCC) and the Tel Aviv Stock
Exchange (TASE: MCC). Medley Capital Corporation's investment
objective is to generate current income and capital appreciation by
lending to privately-held middle market companies, primarily
through directly originated transactions, to help these companies
expand their businesses, refinance and make acquisitions. Our
portfolio generally consists of senior secured first lien loans and
senior secured second lien loans. Medley Capital Corporation is
externally managed by MCC Advisors LLC, which is an investment
adviser registered under the Investment Advisers Act of 1940, as
amended. For additional information, please visit Medley Capital
Corporation at www.medleycapitalcorp.com.
ABOUT MCC ADVISORS LLC
MCC Advisors LLC is a subsidiary of Medley
Management Inc. (NYSE: MDLY, “Medley”). Medley is an alternative
asset management firm offering yield solutions to retail and
institutional investors. Medley’s national direct origination
franchise is a premier provider of capital to the middle market in
the U.S. Medley has $4.7 billion of assets under management in two
business development companies, Medley Capital Corporation (NYSE:
MCC) (TASE: MCC) and Sierra Income Corporation, a credit interval
fund, Sierra Total Return Fund (NASDAQ:SRNTX) and several private
investment vehicles. Over the past 15 years, we have provided
capital to over 400 companies across 35 industries in North
America.2 For additional information, please visit Medley
Management Inc. at www.mdly.com.
Medley LLC, the operating company of Medley
Management Inc., has outstanding bonds which trade on the New York
Stock Exchange under the symbols (NYSE:MDLX) and (NYSE:MDLQ).
Medley Capital Corporation is dual-listed on the New York Stock
Exchange (NYSE:MCC) and the Tel Aviv Stock Exchange (TASE: MCC) and
has outstanding bonds which trade on both the New York Stock
Exchange under the symbols (NYSE:MCV), (NYSE:MCX) and the Tel Aviv
Stock Exchange under the symbol (TASE: MCC.B1).
NO OFFER OR
SOLICITATION
The information in this communication is for
informational purposes only and shall not constitute an offer to
sell or the solicitation of an offer to sell or the solicitation of
an offer to buy any securities or the solicitation of any vote or
approval in any jurisdiction pursuant to or in connection with the
proposed transactions or otherwise, nor shall there be any sale,
issuance or transfer of securities in any jurisdiction in
contravention of applicable law. No offer of securities shall be
made except by means of a prospectus meeting the requirements of
Section 10 of the Securities Act of 1933, as amended.
IMPORTANT INFORMATION AND WHERE TO FIND
IT
In connection with the proposed transactions,
Sierra has filed with the Securities and Exchange Commission (the
“SEC”) a Registration Statement on Form N-14 that includes a joint
proxy statement of Sierra, the Company, and MDLY and, with respect
to Sierra, constitutes a prospectus (collectively, the “Joint Proxy
Statement/Prospectus”). The Joint Proxy Statement/Prospectus, as
applicable, was first mailed or otherwise delivered to stockholders
of Sierra, the Company, and MDLY on or about December 21, 2018.
INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE JOINT PROXY
STATEMENT/PROSPECTUS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO
THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY
CONTAIN IMPORTANT INFORMATION ABOUT SIERRA, THE COMPANY, AND MDLY,
THE PROPOSED TRANSACTIONS AND RELATED MATTERS. Investors and
security holders can obtain the Joint Proxy Statement/Prospectus
and other documents filed with the SEC by Sierra, the Company, and
MDLY, free of charge, from the SEC’s web site at www.sec.gov and
from Sierra’s website (www.sierraincomecorp.com), the Company’s
website (www.medleycapitalcorp.com), or MDLY’s website
(www.mdly.com). Investors and security holders may also obtain free
copies of the Joint Proxy Statement/Prospectus and other documents
filed with the SEC from Sierra, the Company, or MDLY by contacting
Sam Anderson, Medley’s Investor Relations contact, at
212-759-0777.
PARTICIPANTS IN THE
SOLICITATION
Sierra, the Company, and MDLY and their
respective directors, executive officers, other members of their
management, employees and other persons may be deemed to be
participants in the solicitation of proxies in connection with the
proposed transactions. Information regarding the persons who may,
under the rules of the SEC, be considered participants in the
solicitation of the Sierra, the Company, and MDLY stockholders in
connection with the proposed transactions is set forth in the Joint
Proxy Statement/Prospectus filed with the SEC. More detailed
information regarding the identity of potential participants, and
their direct or indirect interests, by security holdings or
otherwise, is set forth in the Joint Proxy Statement/Prospectus and
in other relevant materials that may be with the SEC. These
documents may be obtained free of charge from the sources indicated
above.
CAUTIONARY STATEMENT REGARDING
FORWARD-LOOKING STATEMENTS
This communication contains “forward-looking”
statements, including statements regarding the proposed
transactions. Such forward-looking statements reflect current views
with respect to future events and financial performance, and the
Company may make related oral forward-looking statements on or
following the date hereof. Statements that include the words
“should,” “would,” “expect,” “intend,” “plan,” “believe,”
“project,” “anticipate,” “seek,” “will,” and similar statements of
a future or forward-looking nature identify forward-looking
statements in this material or similar oral statements for purposes
of the U.S. federal securities laws or otherwise. Because
forward-looking statements, such as the date that the parties
expect the proposed transactions to be completed and the
expectation that the proposed transactions will provide sustainable
and increased profits, greater likelihood of dividend growth, lower
cost of capital and improved liquidity for the Company’s
stockholders and will be accretive to net investment income for the
Company, include risks and uncertainties, actual results may differ
materially from those expressed or implied and include, but are not
limited to, those discussed in the Company’s filings with the SEC,
and (i) the satisfaction or waiver of closing conditions relating
to the proposed transactions described herein, including, but not
limited to, the requisite approvals of the stockholders of each of
Sierra, the Company, and MDLY, Sierra successfully taking all
actions reasonably required with respect to certain outstanding
indebtedness of the Company and MDLY to prevent any material
adverse effect relating thereto, certain required approvals
of the SEC, the necessary consents of certain third-party advisory
clients of MDLY, and any applicable waiting period (and any
extension thereof) applicable to the transactions under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended,
shall have expired or been terminated, (ii) the parties’ ability to
successfully consummate the proposed transactions, and the timing
thereof, and (iii) the possibility that competing offers or
acquisition proposals related to the proposed transactions will be
made and, if made, could be successful. Additional risks and
uncertainties specific to the Company include, but are not limited
to, (i) the costs and expenses that the Company has, and may incur,
in connection with the proposed transactions (whether or not they
are consummated), (ii) the impact that any litigation relating to
the proposed transactions may have on the Company, (iii) that
projections with respect to dividends may prove to be incorrect,
(iv) the market performance of the combined portfolio, (v) the
ability of portfolio companies to pay interest and principal in the
future; (vii) whether Sierra, as the surviving company, will trade
with more volume and perform better than the Company prior to the
proposed transactions; and (ix) negative effects of entering into
the proposed transactions on the trading volume and market price of
the Company’s common stock. There can be no assurance of the level
of any dividends to be paid, if any, following consummation of the
merger. Investors are cautioned that, as a result of a number of
factors (including those described above), there remains
substantial uncertainty regarding the ability of MCC and Sierra to
successfully consummate MCC’s proposed merger with Sierra.
The foregoing review of important factors should
not be construed as exhaustive and should be read in conjunction
with the other cautionary statements included in each of the
Company’s, Sierra’s and MDLY’s filings with the SEC, including the
Joint Proxy Statement/Prospectus relating to the proposed
transactions, and in the “Risk Factors” sections of each of the
Company’s, Sierra’s, and MDLY’s most recent Annual Report on Form
10-K and most recent Quarterly Report on Form 10-Q. The forward-
looking statements in this communication represent the Company’s
views as of the date of hereof. The Company anticipates that
subsequent events and developments will cause its views to change.
However, while the Company may elect to update these
forward-looking statements at some point in the future, the Company
has the current intention of doing so except to the extent required
by applicable law. You should, therefore, not rely on these
forward-looking statements as representing the Company’s views as
of any date subsequent to the date of this material.
SOURCE: Medley Capital Corporation
Investor Relations Contact: Sam AndersonHead of Capital Markets
& Risk Management Medley Management Inc. 212-759-0777
Media Contact: Jonathan Gasthalter/Nathaniel GarnickGasthalter
& Co. LP212-257-4170
____________________1 See Cautionary Statement Regarding
Forward-Looking Statements for additional information.2 Medley
Management Inc. is the parent company of Medley LLC and several
registered investment advisors (collectively, ”Medley”). Assets
under management refers to assets of our funds, which represents
the sum of the net asset value of such funds, the drawn and undrawn
debt (at the fund level, including amounts subject to restrictions)
and uncalled committed capital (including commitments to funds that
have yet to commence their investment periods). Assets under
management are as of December 31, 2018.
Medley (NYSE:MDLX)
Historical Stock Chart
From Jan 2025 to Feb 2025
Medley (NYSE:MDLX)
Historical Stock Chart
From Feb 2024 to Feb 2025